Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica Wins Japanese Pharma Customer for Predictive ADME Software

NEW YORK, Oct. 11 (GenomeWeb News) - Inpharmatica has licensed its Admensa Interactive predictive ADME software to Japanese pharmaceutical company Mochida, the company said today.

 

This is the second Japanese company that has licensed Admensa Interactive, and the sixth overall since Inpharmatica launched the product in February.

 

The agreement was secured in conjunction with PharmaDesign, Inpharmatica's sales and marketing partner in Japan, Inpharmatica said.

 

Financial details of the agreement were not disclosed.